Logo

Similar Products

Description

Miacalcic Nasal 200 Spray is a trusted pharmaceutical solution containing calcitonin, specifically designed for nasal administration to treat bone and metabolic disorders. It offer...
Miacalcic Nasal 200 Spray is a trusted pharmaceutical solution containing calcitonin, specifically designed for nasal administration to treat bone and metabolic disorders. It offers an effective alternative to injectable formulations, ensuring precise dosing and ease of use for patients requiring long-term therapy. Manufactured under stringent quality standards, this spray provides reliable therapeutic outcomes that healthcare providers trust. The patient-friendly design maintains high bioavailability while ensuring each dose delivers intended medical benefits without complications, making it suitable for extended treatment regimens.

This product is extensively used in endocrinology for postmenopausal osteoporosis management, in oncology for cancer-related bone pain, and in neurology for neurodystropic disorders. Hospitals, specialty clinics, and rehabilitation centers incorporate it into treatment protocols due to its proven efficacy and non-invasive nature. Geriatric care facilities utilize it to support bone health in elderly patients, while distributors supply it to pharmacies, healthcare institutions, and medical programs to ensure broad patient accessibility across various healthcare systems.

Businesses value Miacalcic Nasal 200 Spray for its demonstrated reliability, compliance with international quality standards, and consistent performance that reduces treatment uncertainties. Its reputation for therapeutic effectiveness builds trust among medical professionals and patients alike. For distributors, it represents a high-demand product with steady reorder potential, supported by clear clinical benefits and proven results. The spray's quality construction and dependable performance make it a sustainable choice for healthcare providers seeking long-term treatment solutions.

Key Features:
- Contains 200 doses per spray bottle for extended treatment duration
- Nasal delivery system enabling non-invasive administration
- High-purity calcitonin formulation ensuring reliable efficacy
- Manufactured under strict pharmaceutical quality control standards
- Consistent dosing accuracy for predictable therapeutic outcomes

Benefits:
- Extended treatment capacity reduces frequency of replacements
- Non-invasive administration improves patient comfort and compliance
- Reliable therapeutic effects from high-purity active ingredients
- Consistent quality assurance through rigorous manufacturing controls
- Predictable dosing supports accurate treatment planning and outcomes

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Miacalcic Nasal 200 Spray serves hospitals, clinics, and long-term care facilities managing bone-related conditions. Its nasal delivery provides a non-invasive alternative to injections, enhancing patient comfort and treatment adherence during extended therapies. This makes it ideal for both inpatient and outpatient settings where administration ease is prioritized.

The spray effectively addresses postmenopausal osteoporosis, malignancy-related bone pain, and neurodystropic disorders. It is particularly valuable in oncology, endocrinology, and geriatric medicine, delivering targeted relief while supporting bone density maintenance. Healthcare professionals depend on its consistent dosing accuracy and patient-centric design for reliable outcomes.
- Managing osteoporosis in postmenopausal women to reduce fracture risks
- Alleviating bone pain in patients with metastatic bone diseases
- Treating neurodystropic disorders like Sudeck's atrophy effectively
- Supporting cancer patients experiencing osteolysis-related discomfort
- Administering calcitonin therapy through convenient nasal delivery

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Cash on Delivery (COD, if applicable)

Company Profile

Aark Pharmaceuticals
Aark Pharmaceuticals, New Delhi
Verified
IndiaNew Delhi, India
Trading CompanyDistributor / WholesalerImporter / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Healthcare Miacalcic Nasal 200 Spray For Osteoporosis Bone Pain

Miacalcic Nasal 200 Spray treats osteoporosis, bone pain, and neurodystropic disorders with reliable calcitonin therapy. Trusted by healthcare providers for consistent therapeutic results and patient-friendly nasal administration.

Min. Order Quantity: 1 units

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Aark Pharmaceuticals
Verified
IndiaNew Delhi, India
Trading Company

More Products From Supplier

No supplier products found.

Related Products